Aspirin for Acute Stroke of Undetermined Etiology in Resource-Limited Settings: A Decision Analysis (P4.296)

CONCLUSIONS: Aspirin initiation after acute stroke of unknown etiology in resource-limited settings is predicted to decrease acute stroke-related mortality and stroke recurrence. The assumption that aspirin cannot be safely administered to patients with acute stroke of unknown etiology without neuroimaging to assess for ICH is not supported by our model. In the absence of a clinical trial to test this approach empirically, clinical decisions still require patient-specific scrutiny.Disclosure: Dr. Berkowitz has received royalty payments from Medmaster and Oxford University Press. Dr. Westover has received personal compensation for activities with the American Brain Foundation. Dr. Westover has received research support from the National Institutes of Health. Dr. Bianchi has received research support from Pfizer Inc., and Merck & Co, Inc. Dr. Chou has received research support from the National Institutes of Health, the American Heart Association, and Novartis.

Source: Neurology - April 9, 2014 Category: Neurology Authors: Berkowitz, A., Westover, M., Bianchi, M., Chou, S. Tags: Global Health and Infection Source Type: research